Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study.
Toshihiko MatsumotoShogo YamamuraTatsuki IkomaYusuke KuriokaKeitaro DoiTomoyo YasudaShogen BokuTakashi KawaiNobuhiro ShibataHiroki NagaiTakao TsudukiTakanobu ShimadaYusuke MatsumotoTakehiko TsumuraMasahiro TakataniHisateru YasuiHironaga SatakePublished in: Clinical Medicine Insights. Oncology (2022)
In a real-world setting, FTD/TPI has similar effectiveness as late-line chemotherapy for patients with AGC, including those who previously had received nivolumab.